Edition:
India

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

59.55EUR
19 Jul 2019
Change (% chg)

€0.79 (+1.34%)
Prev Close
€58.76
Open
€59.59
Day's High
€60.03
Day's Low
€59.03
Volume
3,075,454
Avg. Vol
3,637,683
52-wk High
€97.03
52-wk Low
€52.02

Select another date:

Fri, Jul 19 2019

Syngenta CFO says it faces no glyphosate lawsuits

ZURICH, July 19 Chinese-owned agricultural chemical maker Syngenta has not been named in litigation involving weed-killer ingredient glyphosate that has hit German rival Bayer, the Swiss-based company's chief financial officer, Mark Patrick, said on Friday.

Bayer welcomes judge's call for reduced damages in $2 billion glyphosate case

FRANKFURT Germany's Bayer AG welcomed on Friday a call by a U.S. judge to cut a $2 billion damages award to a Californian couple by a jury which found that its glyphosate-based weed killer had caused their cancer.

UPDATE 1-Bayer welcomes judge's call for reduced damages in $2 bln glyphosate case

* Bayer faces 13,400 U.S. lawsuits over Roundup weed killer (Writes through with detail on damages award, context)

CORRECTED-Bayer welcomes judge's call for damages to be cut in $2 billion glyphosate case

FRANKFURT, July 19 Germany's Bayer AG on Friday welcomed a conditional ruling by a U.S. judge calling for the reduction of a $2 billion damages award to a couple by a jury who found that its glyphosate-based weed killer caused their cancer.

European shares flat, Bayer boosted by new Roundup ruling

July 16 European shares opened little changed on Tuesday as investors looked to a deluge of second quarter earnings releases and a batch of macroeconomic indicators for more signs on a slowing global and euro zone economy.

U.S. judge slashes Roundup jury award to $25.3 million; Bayer still plans to appeal

A federal judge on Monday slashed a damages award Bayer AG owed a California man who blamed Roundup weed killer for his cancer, to $25.27 million from $80.27 million, while rejecting the company's bid for a new trial.

U.S. judge slashes Roundup jury award to $25.3 million; Bayer still plans to appeal

A federal judge on Monday slashed a damages award Bayer AG owed a California man who blamed Roundup weed killer for his cancer, to $25.27 million from $80.27 million, while rejecting the company's bid for a new trial.

UPDATE 3-U.S. judge slashes Roundup jury award to $25.3 mln; Bayer still plans to appeal

July 15 A federal judge on Monday slashed a damages award Bayer AG owed a California man who blamed Roundup weed killer for his cancer, to $25.27 million from $80.27 million, while rejecting the company's bid for a new trial.

Bayer's MRI contrast agent gets FDA approval for use in cardiac disease

Bayer AG on Monday said U.S. regulators approved its contrast agent for use in magnetic resonance imaging (MRI) to assess patients with known or suspected coronary artery disease.

Bayer's MRI contrast agent gets FDA approval for use in cardiac disease

July 15 Bayer AG on Monday said U.S. regulators approved its contrast agent for use in magnetic resonance imaging (MRI) to assess patients with known or suspected coronary artery disease.

Select another date: